Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Generation of an induced pluripotent stem cell line from a malignant melanoma patient who developed the immune checkpoint inhibitor-related myasthenia gravis, myositis, and myocarditis overlap syndrome

Stem Cell Research(2025)10.1016/j.scr.2025.103797Source: DataRank Database

Generation of an induced pluripotent stem cell line from a malignant melanoma patient who developed the immune checkpoint inhibitor-related myasthenia gravis, myositis, and myocarditis overlap syndrome is a research paper published in Stem Cell Research (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

hPSCreg doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.00)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Chikage Noishiki ORCID,Jacquelyn Lai,Pourya Yarahmadi ORCID,Thao Le ORCID,Dipti Tripathi ORCID

Live enrichment

PubMed:40795579 PMC:PMC12450033 OpenAlex:https://openalex.org/W4413020151

American Heart Association Inc

Grant: 20TPA35500081

American Heart Association Inc

Grant: 23POST1020812

American Heart Association Inc

Grant: 24DIVSUP1288331

National Heart Lung and Blood Institute

Grant: R01 HL158641

National Heart Lung and Blood Institute

Grant: R01 HL161002

NHLBI NIH HHS

Grant: R01 HL134830

NIA NIH HHS

Grant: R01 AG086072

National Institutes of Health

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.scr.2025.103797

GOLDhttps://doi.org/10.1016/j.scr.2025.103797

publisherhttps://doi.org/10.1016/j.scr.2025.103797

publisherhttps://api.elsevier.com/content/article/PII:S1873506125001473?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1873506125001473?httpAccept=text/plain

Fields of Study

CAR-T cell therapy researchCancer Immunotherapy and BiomarkersMelanoma and MAPK PathwaysMedicineHumansMyocarditisInduced Pluripotent Stem CellsMelanomaMyasthenia GravisMyositisImmune Checkpoint InhibitorsMaleMiddle Aged

MeSH Terms

Immune Checkpoint InhibitorsHumansMaleMelanomaMiddle AgedMyasthenia GravisMyocarditisMyositisInduced Pluripotent Stem Cells

Keywords

Myasthenia gravisMyositisBiologyMelanomaMyocarditisImmunologyInduced pluripotent stem cellOverlap syndromeCancer researchInternal medicineMedicineDiseaseAnatomyGeneticsEmbryonic stem cellMalignant melanomaHuman Induced Pluripotent Stem Cell (Ipsc)Immune-Checkpoint-InhibitorsMyasthenia Gravis, Myositis, And Myocarditis Overlap Syndrome

Sustainable Development Goals

SDG 0: Good health and well-being

Generation of an induced pluripotent stem cell line from a malignant melanoma patient who developed the immune checkpoint inhibitor-related myasthenia gravis, myositis, and myocarditis overlap syndrome

FAIR Checklist

Authors (12)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)